Linagliptin Among Filipino Patients With Type 2 Diabetes Mellitus
Status:
Terminated
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
This is a prospective, non-interventional, open label, multi center, post marketing
surveillance study designed to assess the safety, tolerability and efficacy of Linagliptin
among Filipino patients with type 2 Diabetes Mellitus (DM) within the study duration of 24
weeks.